Skip to main content
. Author manuscript; available in PMC: 2013 Oct 28.
Published in final edited form as: J Bone Miner Res. 2011 Aug;26(8):10.1002/jbmr.377. doi: 10.1002/jbmr.377

Fig. 6.

Fig. 6

Real-time RT-PCR analysis showed the expression levels of miR-335-5p in C3H10T1/2 cells (A), MC3T3 cells (B), MLO-A5 cells (C), and MLO-Y4 cells (D) before and after ascorbic acid (AA) treatment. Three independent experiments were performed in triplicate, and data are represented as mean ± SEM. *p < .05, AA-treated cells versus control cells.

HHS Vulnerability Disclosure